Filter announcements
Loading...
Established in the year 1984 and a part of $1000 million Aarti Group of Industries, Aarti Drugs Ltd. (ADL) is engaged into manufacturing and selling Active Pharmaceutical Ingredients (API's), Pharma Intermediates, Specialty Chemicals as well as Formulations.
Aarti Drugs has clarified that the financial figures for the quarter and year ended March 31, 2025, include balancing figures derived between the audited full-year numbers and the year-to-date figures published up to the third quarter. This ensures consistency and alignment with accounting standards and disclosures.
Aarti Drugs Limited has announced a board meeting on January 29, 2025, to present the financial results for the quarter and nine months ended December 31, 2024. The results indicate a revenue of ₹226.69 crore and a net profit of ₹39.06 crore for the quarter. The Board has declared an...